Michael Rosenblatt - Net Worth and Insider Trading
Michael Rosenblatt Net Worth
The estimated net worth of Michael Rosenblatt is at least $139,963 dollars as of 2025-05-09. Michael Rosenblatt is the Director of Azenta Inc and owns about 5,051 shares of Azenta Inc (AZTA) stock worth over $139,963. Details can be seen in Michael Rosenblatt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Rosenblatt has not made any transactions after 2021-11-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Rosenblatt
Michael Rosenblatt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Rosenblatt owns 5 companies in total, including Rubius Therapeutics Inc (RUBY) , Azenta Inc (AZTA) , and Merck & Co Inc (MRK) among others .
Click here to see the complete history of Michael Rosenblatt’s form 4 insider trades.
Insider Ownership Summary of Michael Rosenblatt
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RUBY | Rubius Therapeutics Inc | 2018-07-17 | director |
| AZTA | Azenta Inc | 2021-11-12 | director |
| MRK | Merck & Co Inc | 2009-12-16 | Exec V-P & Chief Med Officer |
 | | 2009-12-16 | Exec V-P & Chief Med Officer |
| | 2022-05-19 | director |
Michael Rosenblatt Latest Holdings Summary
Michael Rosenblatt currently owns a total of 1 stock. Michael Rosenblatt owns 5,051 shares of Azenta Inc (AZTA) as of November 12, 2021, with a value of $139,963.
Latest Holdings of Michael Rosenblatt
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AZTA | Azenta Inc | 2021-11-12 | 5,051 | 27.71 | 139,963 |
Holding Weightings of Michael Rosenblatt
Michael Rosenblatt Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Rosenblatt has made a total of 1 transactions in Azenta Inc (AZTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Azenta Inc is the sale of 2,831 shares on November 12, 2021, which brought Michael Rosenblatt around $323,102.
Insider Trading History of Michael Rosenblatt
- 1
Michael Rosenblatt Trading Performance
Michael Rosenblatt Ownership Network
Ownership Network List of Michael Rosenblatt
Ownership Network Relation of Michael Rosenblatt
Michael Rosenblatt Owned Company Details
What does Rubius Therapeutics Inc do?
Who are the key executives at Rubius Therapeutics Inc?
Michael Rosenblatt is the director of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .
Rubius Therapeutics Inc (RUBY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rubius Therapeutics Inc Insider Transactions
Michael Rosenblatt Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Rosenblatt. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Michael Rosenblatt's mailing address is: Kenilworth Nj 07033.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
